Skip to main content

Amphastar Pharmaceuticals, Inc.

AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001297184

In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.

Superinvestors holding AMPH, Q2 2026

See all superinvestors

No superinvestor reported holding AMPH in Q2 2026.